Cellectar Biosciences Reports Q3 2026 GAAP EPS of -0. ...
Clinical-Stage Biotech Advances Iopofosine I 131 Toward Planned 2027 Filing Related Stocks: CLRB ,
Clinical-Stage Biotech Advances Iopofosine I 131 Toward Planned 2027 Filing Related Stocks: CLRB ,